Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Drug

    • Home
    • Drug
    • Page 287
Drug Medical Device

Shanghai Roche Pharmaceuticals Launches Erlotinib for Advanced Non-Small Cell Lung Cancer in China

Fineline Cube Apr 4, 2007

Shanghai Roche Pharmaceuticals Ltd. made headlines in March with the launch of its lung cancer...

Posts pagination

1 … 286 287

Recent updates

  • Jemincare JMX-2005 PAD Injection Secures NMPA Clinical Trial Approval
  • J&J TREMFYA Pediatric Psoriasis EC Approval Targets First IL-23 Indication
  • Takeda Zasocitinib TYK2 Phase III Shows Positive Psoriasis Results
  • Lilly Imlunestrant Breast-Cancer EMBER-3 Shows 38% Risk Reduction
  • IVIEW GVB-2001 Gene Therapy Treats First POAG Patient Successfully
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Drug

Jemincare JMX-2005 PAD Injection Secures NMPA Clinical Trial Approval

Company Drug

J&J TREMFYA Pediatric Psoriasis EC Approval Targets First IL-23 Indication

Company Drug

Takeda Zasocitinib TYK2 Phase III Shows Positive Psoriasis Results

Company Drug

Lilly Imlunestrant Breast-Cancer EMBER-3 Shows 38% Risk Reduction

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.